Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
    • +

      P01.01 - HERTHENA-Lung01: A Randomized Phase 2 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Previously Treated Metastatic EGFR-mutated NSCLC

      00:00 - 00:00  |  Presenter: Pasi A. Janne

      • Abstract

      Loading...

    • +

      P01.02 - Trastuzumab Deruxtecan Plus Pembrolizumab in Advanced/Metastatic Breast or Non-Small Cell Lung Cancer: A Phase 1b Study

      00:00 - 00:00  |  Presenter: Hossein Borghaei

      • Abstract

      Loading...

    • +

      P01.03 - Phase 1 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Combination with Osimertinib in Patients with Locally Advanced or Metastatic EGFR-mutated NSCLC

      00:00 - 00:00  |  Presenter: Pasi Antero Jänne

      • Abstract

      Loading...

    • +

      P01.04 - Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

      00:00 - 00:00  |  Presenter: Pasi Antero Jänne

      • Abstract

      Loading...

    • +

      P01.05 - Pilot Study of Inhaled Azacitidine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Haiying Cheng

      • Abstract

      Loading...

    • +

      P01.06 - CX-2029, a Probody Drug Conjugate Targeting CD71 in Patients With Selected Tumor Types: PROCLAIM-CX-2029 Dose Expansion Phase

      00:00 - 00:00  |  Presenter: Melissa L Johnson

      • Abstract

      Loading...

    • +

      P01.07 - Real World Outcomes of Advanced Non-Small Cell Lung Cancer (NSCLC) With Attention to Carboplatin Area Under the Curve (AUC) = 5 Versus 6

      00:00 - 00:00  |  Presenter: Lindsey Fitzgerald

      • Abstract

      Loading...

    • +

      P01.08 - Evaluation of Long-Term Pemetrexed Responders in a United States Cohort

      00:00 - 00:00  |  Presenter: Sylvia Vania Alarcon

      • Abstract

      Loading...

    • +

      P01.09 - Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy

      00:00 - 00:00  |  Presenter: Kunal Gawri

      • Abstract

      Loading...

    • +

      P01.10 - Patients Experienced Pseudoprogression to Anti-PD-1/PD-L1 Inhibitor Have Better Response Than Those Without in Lung Cancer

      00:00 - 00:00  |  Presenter: Wencheng Zhao

      • Abstract

      Loading...

    • +

      P01.11 - Clinical Outcomes After Discontinuation of Immunotherapy in Patients With Non-Progressing Metastatic Lung Cancer

      00:00 - 00:00  |  Presenter: Matias Alejandro Cerini

      • Abstract

      Loading...

    • +

      P01.12 - Brain Necrosis in Patients With Metastatic Lung and Breast Cancer Successfully Treated With Bevacizumab

      00:00 - 00:00  |  Presenter: Luis E. Raez

      • Abstract

      Loading...

    • +

      P01.13 - Anti-PD1 Inhibitors Combined With Anti-Angiogenesis Showed Superior Efficacy in Control of Malignant Pleural Effusion for NSCLC

      00:00 - 00:00  |  Presenter: Wencheng Zhao

      • Abstract

      Loading...

    • +

      P01.14 - Safety and Feasibility of Standard Dosing Carboplatin AUC 5 Every 3rd Weeks With Daily Navelbine® 20/30mg During 4 Cycles, Treating Advanced NSCLC

      00:00 - 00:00  |  Presenter: Maria Kandi

      • Abstract

      Loading...

    • +

      P01.15 - Immune-Related Adverse Effects of Immunotherapy in Patients With Advanced Non-Small Cell Lung Carcinoma

      00:00 - 00:00  |  Presenter: Cláudia Freitas

      • Abstract

      Loading...

    • +

      P01.16 - Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells

      00:00 - 00:00  |  Presenter: Yun-Ting He

      • Abstract

      Loading...

    • +

      P01.17 - An Exploratory Study of Associating Factors for Disease Progression After Response to Immune Checkpoint Inhibitor Monotherapy

      00:00 - 00:00  |  Presenter: Osamu Kanai

      • Abstract

      Loading...

    • +

      P01.18 - Adjuvant Chemotherapy With Modified Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC: Survival Analysis of FAST-Nab.

      00:00 - 00:00  |  Presenter: HISASAHI Saji

      • Abstract

      Loading...

    • +

      P01.19 - Real-World Treatment Patterns in Treatment-Naïve Advanced NSCLC Patients in Asia: A Systematic Literature Review

      00:00 - 00:00  |  Presenter: Adam Lee

      • Abstract

      Loading...

    • +

      P01.20 - Short-Term Effificacy of Intrapleural Hyperthermic Perfusion for Malignant Pleural Effusion in Lung Carcinoma

      00:00 - 00:00  |  Presenter: Minhua Ye

      • Abstract

      Loading...

    • +

      P01.21 - ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era

      00:00 - 00:00  |  Presenter: Jordi Remon

      • Abstract

      Loading...

    • +

      P01.22 - Outcomes in NSCLC Patients with Early Termination of Immune Checkpoint Inhibitors Due to Toxicities

      00:00 - 00:00  |  Presenter: Amy Georgina Davies

      • Abstract

      Loading...

    • +

      P01.23 - Veliparib (V) in Combination with Carboplatin/Paclitaxel (C/P)-Based Chemoradiotherapy (CRT) in Patients With Stage III NSCLC

      00:00 - 00:00  |  Presenter: David Kozono

      • Abstract

      Loading...

    • +

      P01.24 - Ramucirumab + Docetaxel (DOC) vs PBO + DOC for Stage IV NSCLC after Disease Progression (REVEL): Indian Sub-Group Analysis

      00:00 - 00:00  |  Presenter: Kumar Prabhash

      • Abstract

      Loading...

  • +

    P02 - Diagnostics and Interventional Pulmonology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Diagnostics and Interventional Pulmonology
    • +

      P02.01 - Evaluation of PFS for Pulmonary Adenocarcinoma Patient Treated With EGFR Tyrosine Kinase Inhibitors Using Deep Learning Based on CT Image

      00:00 - 00:00  |  Presenter: Junfeng Xiong

      • Abstract

      Loading...

    • +

      P02.02 - Pulmonary Rebiopsy is ‘Here to Stay’ in Non-Small Cell Lung Carcinoma (NSCLC) Patients with Progression on Tyrosine Kinase Inhibitors (TKIs)

      00:00 - 00:00  |  Presenter: Abhishek Bansal

      • Abstract

      Loading...

    • +

      P02.03 - Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.

      00:00 - 00:00  |  Presenter: Tetsuya Sakai

      • Abstract

      Loading...

    • +

      P02.04 - Pectoral Muscle Area Correlates with LENT Score in Non-Small Cell Lung Cancer Associated Pleural Effusion Survival Prediction

      00:00 - 00:00  |  Presenter: Austin Michael Meggyesy

      • Abstract

      Loading...

    • +

      P02.05 - A Nomogram to Predict Survival in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab: An Analysis of OAK and POPLAR Cohorts

      00:00 - 00:00  |  Presenter: Haiyong Wang

      • Abstract

      Loading...

    • +

      P02.06 - A Novel Loop-Mediated Isothermal Amplification Method for Robust Detection of EGFR Mutations

      00:00 - 00:00  |  Presenter: YUICHI Saito

      • Abstract

      Loading...

    • +

      P02.07 - Impact of Diagnostic Test Sequencing on Effectiveness, Efficiency and Survival in Metastatic Non-Small Cell Lung Cancer.

      00:00 - 00:00  |  Presenter: Prachi Bhave

      • Abstract

      Loading...

    • +

      P02.08 - A UK Survey of Current Methods for Conducting Cancer Multidisciplinary Team Meetings and Opportunities for Digital Solutions.

      00:00 - 00:00  |  Presenter: Clarissa Gardner

      • Abstract

      Loading...

    • +

      P02.09 - Comprehensive Investigation of Resected Benign Lesions Suspected for Lung Cancer: Implications for Avoiding Unnecessary Pulmonary Resection

      00:00 - 00:00  |  Presenter: Zelin Ma

      • Abstract

      Loading...

    • +

      P02.10 - Patterns of Care for Elderly Patients over Age 80 with Stage IIIA-N2, IIIB, and IIIC NSCLC

      00:00 - 00:00  |  Presenter: Yajie Yin

      • Abstract

      Loading...

    • +

      P02.11 - Treatment Strategy for Postoperative Chylothorax after Lung Cancer Surgery

      00:00 - 00:00  |  Presenter: Chihaya Maeda

      • Abstract

      Loading...

    • +

      P02.12 - Is there a Need for Staging EBUS in Lung Cancer? 

      00:00 - 00:00  |  Presenter: Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.13 - Pneumothorax and CT Guided Biopsy for the Investigation of Lung Cancer

      00:00 - 00:00  |  Presenter: Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.14 - Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19

      00:00 - 00:00  |  Presenter: Abraham J Wu

      • Abstract

      Loading...

    • +

      P02.15 - Intraparenchymal Blood Patch after CT Guided Biopsy of  Lung and Mediastinal Lesions Reduces the Risk of Pneumothorax

      00:00 - 00:00  |  Presenter: Binoy Kumar Choudhury

      • Abstract

      Loading...

    • +

      P02.16 - Rigid Medical Thoracoscopy in a Large UK District General Hospital

      00:00 - 00:00  |  Presenter: Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.17 - Feasibility and Safety of ENB Guided Microwave Ablation for Lung Cancer: A Preliminary Report

      00:00 - 00:00  |  Presenter: Feichao Bao

      • Abstract

      Loading...

    • +

      P02.18 - Indwelling Pleural Catheter Placement in a Large UK District General Hospital

      00:00 - 00:00  |  Presenter: Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.19 - Prognostic Nomogram for Advanced Non-Small Cell Lung Cancer Patients Treated With Anti-PD-1 Inhibitors

      00:00 - 00:00  |  Presenter: Rong Chai

      • Abstract

      Loading...

    • +

      P02.20 - Does Response at 1st Scan Imaging After Any Line Correlate With PFS?

      00:00 - 00:00  |  Presenter: FADI Nasr

      • Abstract

      Loading...

    • +

      P02.21 - The Impact of Inflammatory Serum Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

      00:00 - 00:00  |  Presenter: Élia Rodrigues Cipriano

      • Abstract

      Loading...

    • +

      P02.22 - Identification of FGFR Mutations in Chinese Lung Cancer Patients by Next-Generation Sequencing

      00:00 - 00:00  |  Presenter: HONGXIA Ma

      • Abstract

      Loading...

    • +

      P02.23 - Robotic Thoracic Surgery - A Comparison of Age-Groups Outcomes.

      00:00 - 00:00  |  Presenter: Rui Haddad

      • Abstract

      Loading...

    • +

      P02.24 - Liquid Biopsy Mutation Profiling in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Vaida Gedvilaitė

      • Abstract

      Loading...

    • +

      P02.25 - Coexistence of Invasive Adenocarcinoma, Minimally Invasive Adenocarcinoma and Atypical Adenomatous Hyperplasia: A Case Report

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract

      Loading...

  • +

    P03 - Early Stage/Localized Disease - Clinical Trials in Progress

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P03.01 - A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm

      00:00 - 00:00  |  Presenter: Gregory A Durm

      • Abstract

      Loading...

    • +

      P03.02 - Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA 

      00:00 - 00:00  |  Presenter: Masahiro Tsuboi

      • Abstract

      Loading...

    • +

      P03.03 - MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery

      00:00 - 00:00  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      P03.04 - Phase II Study of TKIs as Neo(adjuvant) Therapy in Stage II–III Resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 Alterations

      00:00 - 00:00  |  Presenter: Jay M. Lee

      • Abstract

      Loading...

    • +

      P03.05 - CANOPY-N: Neoadjuvant Canakinumab and Pembrolizumab in Patients With Surgically Resectable Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Jay M. Lee

      • Abstract

      Loading...

    • +

      P03.06 - Nausea in Patients Had Thoracomy: A Pilot Study

      00:00 - 00:00  |  Presenter: Feng-Ming (Spring) Kong

      • Abstract

      Loading...

  • +

    P04 - Early Stage/Localized Disease - Perioperative Therapy (Neoadjuvant Therapy, Surgery, Adjuvant Therapy)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P04.01 - Adjuvant Chemotherapy is not Associated with Worse Disease-Free Survival in the Elderly Population.  

      00:00 - 00:00  |  Presenter: Luciana Beatriz Mendes Gomes

      • Abstract

      Loading...

    • +

      P04.02 - Three Definitions of Normal Lung Volumes for Predicting Radiation Pneumonitis in Advanced NSCLC Treated With Radical Chemoradiation Therapy

      00:00 - 00:00  |  Presenter: zhiyong Chen

      • Abstract

      Loading...

    • +

      P04.03 - Patient Characteristics and Clinical Outcomes of Stage III NSCLC in a Real-World Setting: KINDLE Korean Subset Data.

      00:00 - 00:00  |  Presenter: Byoung Chul Cho

      • Abstract

      Loading...

    • +

      P04.04 - Thrombus Formation at Stump of Pulmonary Vein after Pulmonary Lobectomy: A Prospective Multi-institutional Study

      00:00 - 00:00  |  Presenter: Takayoshi Yamamoto

      • Abstract

      Loading...

    • +

      P04.05 - Efficacy of Uniportal Video-Assisted Thoracic Surgery (U-VATS) Simple Segmentectomy for Early Lung Cancer

      00:00 - 00:00  |  Presenter: Kyoji Hirai

      • Abstract

      Loading...

    • +

      P04.06 - Early Surgical and Oncological Outcomes After Single Port Video Assisted Thoracoscopic Surgery Lung Resection; KHCC Experience

      00:00 - 00:00  |  Presenter: riad Amin Abdeljalil

      • Abstract

      Loading...

    • +

      P04.07 - Long-term Postoperative Prognosis of Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung

      00:00 - 00:00  |  Presenter: Masaya Yotsukura

      • Abstract

      Loading...

    • +

      P04.08 - Dynamics of Coagulation Factor XIII Activity After Thoracoscopic Lobectomy for Early-Stage Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Yoshikane Yamauchi

      • Abstract

      Loading...

    • +

      P04.09 - Real-Time CT Guided Video-Assisted Thoracoscopic Partial Resection of Peripheral Small-Sized Lung Tumors in Hybrid OR –A Phase 2 Trial–

      00:00 - 00:00  |  Presenter: Taisuke Kaiho

      • Abstract

      Loading...

    • +

      P04.10 - Relapsed or Metastatic Organotropism in Early Stage Lung Cancer after Radical Surgery

      00:00 - 00:00  |  Presenter: Fei Xu

      • Abstract

      Loading...

    • +

      P04.12 - A Novel Lung Autotransplantation Technique for Treating Central Lung Cancer and Bronchial Malignancy

      00:00 - 00:00  |  Presenter: JIAXI He

      • Abstract

      Loading...

  • +

    P05 - Early Stage/Localized Disease - Radiotherapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P05.01 - Multicenter Retrospective Study of Stereotactic Body Radiotherapy in Non-Small Cell Lung Cancer in South Korea (KROG 17-09)

      00:00 - 00:00  |  Presenter: Seung Gyu Park

      • Abstract

      Loading...

    • +

      P05.02 - International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Robert Rulach

      • Abstract

      Loading...

    • +

      P05.03 - Circulating Lymphocyte Counts after Lung Stereotactic Body Radiation Therapy May Predict after Optimal Short-term Efficacy

      00:00 - 00:00  |  Presenter: Meng Chen

      • Abstract

      Loading...

    • +

      P05.04 - Association of Lymphopenia and Disease Progression in Unresectable NSCLC Treated with Definitive Chemoradiation and Immunotherapy

      00:00 - 00:00  |  Presenter: Cole Friedes

      • Abstract

      Loading...

    • +

      P05.05 - Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)

      00:00 - 00:00  |  Presenter: Lisa Van Der Woude

      • Abstract

      Loading...

    • +

      P05.06 - Stereotactic Ablative Radiotherapy for Early Stage Non-Small Lung Cancer and Pulmonary Oligometastases in a New Zealand Population

      00:00 - 00:00  |  Presenter: Nur Azri Bin Haji Mohd Yasin

      • Abstract

      Loading...

    • +

      P05.07 - Single-Fraction Carbon ion Radiotherapy for Patients with Early-Stage Lung Cancer with or without Interstitial Pneumonitis

      00:00 - 00:00  |  Presenter: Takashi Ono

      • Abstract

      Loading...

    • +

      P05.08 - A Propensity Score-Weighted Analysis for SBRT, Lobectomy and Sublobar Resection in Elderly Patients with cStage I NSCLC

      00:00 - 00:00  |  Presenter: Noriko Kishi

      • Abstract

      Loading...

    • +

      P05.09 - Thoracic Re-Irradiation Dose Constraints for Late Lung Fibrosis: Preliminary Modelling Results

      00:00 - 00:00  |  Presenter: Robert Rulach

      • Abstract

      Loading...

    • +

      P05.10 - Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Lung Stereotactic Body Radiation Therapy (SBRT)

      00:00 - 00:00  |  Presenter: Xingzhe Li

      • Abstract

      Loading...

    • +

      P05.11 - Preoperative Low Muscle Quality Predicts Poor Outcomes After Surgery for Early-Stage Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Atsushi Kamigaichi

      • Abstract

      Loading...

    • +

      P05.12 - Hospitalisation Rate in Radical Re-Irradiation of NSCLC are no Different Between Local Recurrences or Second Primaries

      00:00 - 00:00  |  Presenter: Robert Rulach

      • Abstract

      Loading...

    • +

      P05.13 - Central vs Peripheral Thoracic Malignancies Treated with SBRT: Early Outcomes of a Prospective Quality of Life Study

      00:00 - 00:00  |  Presenter: Michael Carrasquilla

      • Abstract

      Loading...

    • +

      P05.14 - Dosimetric Impact of Using the Acuros XB for Planning of SBRT of Centrally Located NSCLC

      00:00 - 00:00  |  Presenter: Hing Ming Hung

      • Abstract

      Loading...

  • +

    P06 - Early Stage/Localized Disease - Multiple Primary Lung Cancer

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P06.01 - Therapeutic Strategies for Metachronous Multiple Primary Lung Cancer

      00:00 - 00:00  |  Presenter: Jitsuo Usuda

      • Abstract

      Loading...

    • +

      P06.02 - Prognostic Factors and Strategies for Metachronous Second Primary Lung Cancer

      00:00 - 00:00  |  Presenter: Dai Shimizu

      • Abstract

      Loading...

    • +

      P06.03 - Regression of the Ground Glass Component in Patients with Multifocal Primary Lung Cancers Receiving Pembrolizumab

      00:00 - 00:00  |  Presenter: Jessica Li

      • Abstract

      Loading...

    • +

      P06.04 - Single-Stage Bilateral Pulmonary Resections by Uniportal Video-Assisted Thoracic Surgery for Multiple Small Nodules

      00:00 - 00:00  |  Presenter: Xiaotong Guo

      • Abstract

      Loading...

  • +

    P07 - Early Stage/Localized Disease - Imaging and Biomarkers

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P07.01 - Less Accuracy of CT and PET in the Evaluation of N1 Node may Result in Overlooking Skip Metastasis of Single Station cN2 Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Satoshi Shiono

      • Abstract

      Loading...

    • +

      P07.02 - Detection of Molecular Residual Disease (MRD) using ctDNA in NSCLC: A Systematic Review and Meta-Analysis

      00:00 - 00:00  |  Presenter: Antonio Galvano

      • Abstract

      Loading...

    • +

      P07.03 - The Impact of PD-L1 Expression on the Prognosis of Early-Stage Resected NSCLC: A Meta-Analysis of Literatures.

      00:00 - 00:00  |  Presenter: Shuai Zhu

      • Abstract

      Loading...

    • +

      P07.04 - Using ctDNA to Detect Minimal Residual Disease after Surgery in Resectable Lung Cancer

      00:00 - 00:00  |  Presenter: Jun Huang

      • Abstract

      Loading...

    • +

      P07.05 - Characterization of Clinicopathologic Features and Molecular Recurrence Risk Profiles in Patients with Early-Stage NSCLC

      00:00 - 00:00  |  Presenter: Sara Riordan

      • Abstract

      Loading...

    • +

      P07.06 - Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity

      00:00 - 00:00  |  Presenter: Vivienne Ilona Rebel

      • Abstract

      Loading...

    • +

      P07.07 - Computed Tomography of Lymph Nodes to Predict Occult pN2 Disease in Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Hiroto Onozawa

      • Abstract

      Loading...

    • +

      P07.08 - IDO Immune Suppression and Post Surgical Toxicity in Patients with Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Dazhi Pang

      • Abstract

      Loading...

  • +

    P08 - Early Stage/Localized Disease - Epidemiology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P08.01 - Prognostic Impact of Second Predominant Pattern in Lung Adenocarcinoma: Analysis From a Large Multicentric European Database

      00:00 - 00:00  |  Presenter: Pietro Bertoglio

      • Abstract

      Loading...

    • +

      P08.03 - Clinicopathological Factors Associated With Recurrence Patterns of Resected Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Tomonari Kinoshita

      • Abstract

      Loading...

    • +

      P08.04 - Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients

      00:00 - 00:00  |  Presenter: Brendon Stiles

      • Abstract

      Loading...

    • +

      P08.05 - Risk Factors Associated with Recurrence Following Curative Therapy for Stage I NSCLC

      00:00 - 00:00  |  Presenter: Emily Brooke Butts

      • Abstract

      Loading...

    • +

      P08.06 - Factors Associated with the Diagnosis of Lymphatic Vascular Invasion and its Impact on Prognosis.

      00:00 - 00:00  |  Presenter: Christine M Hebert

      • Abstract

      Loading...

    • +

      P08.07 - Clinical Characteristics and Treatment Patterns of NSCLC Stage III Patients from Real World

      00:00 - 00:00  |  Presenter: Julia Roeper

      • Abstract

      Loading...

    • +

      P08.08 - Surgical Resection of Non-Small Cell Lung Cancer: Uncertain Resection Margins and Patterns of Recurrence

      00:00 - 00:00  |  Presenter: Hannah Emily Scholes

      • Abstract

      Loading...

    • +

      P08.09 - Optimal Follow Up Care for Patients with P-stage I Non-Small Cell Lung Cancer After Surgical Treatment

      00:00 - 00:00  |  Presenter: Hirotsugu Notsuda

      • Abstract

      Loading...

    • +

      P08.10 - Clinical Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer with Same Pathological Types

      00:00 - 00:00  |  Presenter: Ying Liu

      • Abstract

      Loading...

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P09.01 - Different Administration Routes of Endostar Combined with Chemotherapy in the Treatment of Advanced NSCLC, a Real World Study

      00:00 - 00:00  |  Presenter: Wei Jiang

      • Abstract

      Loading...

    • +

      P09.02 - Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey

      00:00 - 00:00  |  Presenter: Fernanda Estevinho

      • Abstract

      Loading...

    • +

      P09.03 - Thyroid Dysfunction in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (ICI): Outcomes in a Multiethnic Urban Cohort.

      00:00 - 00:00  |  Presenter: Angelica D'Aiello

      • Abstract

      Loading...

    • +

      P09.04 - Changing Survival and Treatment Patterns in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in Alberta, Canada

      00:00 - 00:00  |  Presenter: Matthew Anaka

      • Abstract

      Loading...

    • +

      P09.05 - Surveillance, Patterns of Recurrence and Survivorship in Early Stage Lung Cancer Patients Following Curative Intent Treatment

      00:00 - 00:00  |  Presenter: Sobasha Perera

      • Abstract

      Loading...

    • +

      P09.06 - CNS Metastasis Negatively Impact Overall Survival of Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors. 

      00:00 - 00:00  |  Presenter: Camila Iasmim de Andrade Souza

      • Abstract

      Loading...

    • +

      P09.07 - Oncologists Practices and Perceptions on Management of Brain Metastases from Non-Small Cell Lung Cancers-: A Nationally Representative Survey

      00:00 - 00:00  |  Presenter: Srinivas Chilukuri

      • Abstract

      Loading...

    • +

      P09.08 - Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort

      00:00 - 00:00  |  Presenter: Heidi A.I. Grosjean

      • Abstract

      Loading...

    • +

      P09.09 - Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

      00:00 - 00:00  |  Presenter: Maria Fernanda Simões

      • Abstract

      Loading...

    • +

      P09.10 - Nationwide Effect of High Procedure Volume in Lung Cancer Surgery on In-House Mortality in Germany

      00:00 - 00:00  |  Presenter: Philip Baum

      • Abstract

      Loading...

    • +

      P09.11 - Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).

      00:00 - 00:00  |  Presenter: Saul Campos-Gomez

      • Abstract

      Loading...

    • +

      P09.12 - SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?

      00:00 - 00:00  |  Presenter: Virginia Calvo

      • Abstract

      Loading...

    • +

      P09.13 - Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab

      00:00 - 00:00  |  Presenter: Parthib Das

      • Abstract

      Loading...

    • +

      P09.14 - Predictive Analytics in Real-World Data from Peru: The New Models for Personalized Oncology.

      00:00 - 00:00  |  Presenter: Luis Pino

      • Abstract

      Loading...

    • +

      P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19

      00:00 - 00:00  |  Presenter: Laia Fernández-Mañas

      • Abstract

      Loading...

    • +

      P09.16 - Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC). Real-Life Experience from Castile and Leon

      00:00 - 00:00  |  Presenter: Soledad Medina Valdivieso

      • Abstract

      Loading...

    • +

      P09.17 - Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)

      00:00 - 00:00  |  Presenter: Kathryn Banfill

      • Abstract

      Loading...

    • +

      P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

      00:00 - 00:00  |  Presenter: Umit Tapan

      • Abstract

      Loading...

    • +

      P09.19 - Health Disparities Characteristics in Cancer Survivorships among Sexual Minorities in the US - A Cross-Sectional Study Using BRFSS 2018 Data

      00:00 - 00:00  |  Presenter: Yannan Li

      • Abstract

      Loading...

    • +

      P09.20 - Impact of Antibiotics During Immune Checkpoint Inhibitor (ICI) Therapy for Non-Small Cell Lung Cancer: A Real-World Analysis

      00:00 - 00:00  |  Presenter: Ajeet Gajra

      • Abstract

      Loading...

    • +

      P09.22 - Curative Intent Treatment for Small Cell Lung Cancer in England

      00:00 - 00:00  |  Presenter: Susan Harden

      • Abstract

      Loading...

    • +

      P09.23 - Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study

      00:00 - 00:00  |  Presenter: Alastair Greystoke

      • Abstract

      Loading...

    • +

      P09.24 - Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution

      00:00 - 00:00  |  Presenter: Tania Paytan

      • Abstract

      Loading...

    • +

      P09.25 - Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Monica Peravali

      • Abstract

      Loading...

    • +

      P09.26 - Cause of Death in Patients with Squamous Cell Lung Cancer (SCC) Treated with Surgery

      00:00 - 00:00  |  Presenter: Nirav Nicholas Antao

      • Abstract

      Loading...

    • +

      P09.27 - Descriptive Review of Breast Cancer Patients With Subsequent Lung Cancer

      00:00 - 00:00  |  Presenter: Mah Noor

      • Abstract

      Loading...

    • +

      P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period

      00:00 - 00:00  |  Presenter: Teresa Gorría

      • Abstract

      Loading...

    • +

      P09.29 - Immune-Related Adverse Events and their Association with Effectiveness of PD-1/PD-L1 Inhibitors in NSCLC: A Real-World Study from China

      00:00 - 00:00  |  Presenter: Xiaoling Chen

      • Abstract

      Loading...

    • +

      P09.30 - A Clinical and Molecular Portrait of a Younger Population with Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Sophie Stock-Martineau

      • Abstract

      Loading...

    • +

      P09.31 - Adherence to Treatment Recommendations from Multidisciplinary Tumor Boards

      00:00 - 00:00  |  Presenter: Julia Roeper

      • Abstract

      Loading...

    • +

      P09.32 - Is the New Patient Respiratory Appointment an Appropriate Time to Refer Patients With Likely Lung Cancer for Prehabilitation?

      00:00 - 00:00  |  Presenter: Lauren Glanville

      • Abstract

      Loading...

    • +

      P09.33 - Outcomes of Patients with Lung Cancer Tested for COVID-19 in a Chicago Hospital System (LungCOVID-Chicago)

      00:00 - 00:00  |  Presenter: Ryan Nguyen

      • Abstract

      Loading...

    • +

      P09.34 - Curating Online Journal Clubs to Advance Global Oncology Lung Cancer Care

      00:00 - 00:00  |  Presenter: Ian J Pereira

      • Abstract

      Loading...

    • +

      P09.35 - COVID-19 in Patients with Lung Cancer – Experience from a Thoracic Oncology Center

      00:00 - 00:00  |  Presenter: David Coelho

      • Abstract

      Loading...

    • +

      P09.36 - Impact of Medicaid Enrollment on Mortality in Elderly Dual-Eligible Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Meera Ragavan

      • Abstract

      Loading...

    • +

      P09.37 - Pragmatic Trial Design to Compare Surveillance Strategies for Patients with Small Pulmonary Nodules: The Watch the Spot Trial

      00:00 - 00:00  |  Presenter: Beth Creekmur

      • Abstract

      Loading...

    • +

      P09.38 - 2020: COVID19 Impact in Lung Cancer Resection in a University Hospital of Brazil

      00:00 - 00:00  |  Presenter: Paulo Alfredo Casanova Schulze

      • Abstract

      Loading...

    • +

      P09.39 - PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel – Analysis of Real-World Data.

      00:00 - 00:00  |  Presenter: Sarah Sharman Moser

      • Abstract

      Loading...

    • +

      P09.40 - Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China

      00:00 - 00:00  |  Presenter: Joseph Siu-Kie Au

      • Abstract

      Loading...

    • +

      P09.41 - Body Mass Index (BMI) Is Associated With Overall Survival in Patients With Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Maria Fernanda Medeiros

      • Abstract

      Loading...

    • +

      P09.42 - Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study

      00:00 - 00:00  |  Presenter: Marta Soares

      • Abstract

      Loading...

    • +

      P09.43 - Familial History of Cancer and Overall Survival in NSCLC Patients.

      00:00 - 00:00  |  Presenter: Débora Maciel Santana

      • Abstract

      Loading...

    • +

      P09.44 - Outcomes of Covid-19 Infection in Lung Cancer Patients: Experience from a Large Tertiary Care Cancer Center

      00:00 - 00:00  |  Presenter: Kiran Munawar

      • Abstract

      Loading...

    • +

      P09.45 - Ten Year Report of Lung Cancer in Never Smokers from Southeast of Brasil

      00:00 - 00:00  |  Presenter: sabina bandeira Aleixo

      • Abstract

      Loading...

    • +

      P09.46 - Non-Small Cell Lung Cancer Comorbid with Tuberculosis is Associated with Better Prognosis

      00:00 - 00:00  |  Presenter: Ho-Sheng Lee

      • Abstract

      Loading...

    • +

      P09.47 - Implementation of Lung Cancer Multidisciplinary Care: A Rapid Review of Evidence-Practice Gaps

      00:00 - 00:00  |  Presenter: Nicole Rankin

      • Abstract

      Loading...

    • +

      P09.48 - Experience and Outcome of COVID-19-Positive Lung Cancer Patients from a Eastern Indian Hospital

      00:00 - 00:00  |  Presenter: Satya Mantha Padmaja

      • Abstract

      Loading...

    • +

      P09.49 - Experience with Immunotherapy Treatment in Fundación Santa Fe Bogotá: Real World Data in Metastatic Non-Small Cell Lung Cancer Patients.

      00:00 - 00:00  |  Presenter: Aylen Vanessa Ospina Serrano

      • Abstract

      Loading...

    • +

      P09.50 - Lung Cancer Hospitalization Burden. Generating Knowledge from Administrative Data to Optimize Management.

      00:00 - 00:00  |  Presenter: Virginia Calvo

      • Abstract

      Loading...

    • +

      P09.51 - Lung Adenocarcinoma in Morocco

      00:00 - 00:00  |  Presenter: Ouassima Erefai

      • Abstract

      Loading...

    • +

      P09.52 - Explore-LC: Uniting Existing Real-World Date Sources to Create a Novel Asia-Pacific Wide Research Platform for Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: David Horsburgh

      • Abstract

      Loading...

    • +

      P09.53 - Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data

      00:00 - 00:00  |  Presenter: Laura Iadeluca

      • Abstract

      Loading...

    • +

      P09.54 - Pneumonitis Following Durvalumab: A Real-World Analysis in Patients with Lung Cancer and Other Tumor Types

      00:00 - 00:00  |  Presenter: Ajeet Gajra

      • Abstract

      Loading...

    • +

      P09.55 - A Platform to Prospectively Link Real-World Clinico-Genomic, Imaging, and Outcomes Data for Patients With Lung Cancer

      00:00 - 00:00  |  Presenter: Guneet Walia

      • Abstract

      Loading...

    • +

      P09.56 - Real-World Outcomes Among Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Lauren Bartolome

      • Abstract

      Loading...

    • +

      P09.57 - Estimating the Total US Incidence of Advanced/Metastatic Non-Small Cell Lung (NSCLC) Including Recurrent Disease

      00:00 - 00:00  |  Presenter: Shervin J Shirvani

      • Abstract

      Loading...

    • +

      P09.58 - Replication of Overall Survival in Chemotherapy Arms of 1L NSCLC Trials using Real-World Data External Controls

      00:00 - 00:00  |  Presenter: Navdeep Pal

      • Abstract

      Loading...

    • +

      P09.59 - Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece

      00:00 - 00:00  |  Presenter: KONSTANTINOS Syrigos

      • Abstract

      Loading...

    • +

      P09.60 - Using Patient-Level Data from Electronic Health Records to Replicate PFS Outcomes for Four 1L NSCLC Trials

      00:00 - 00:00  |  Presenter: Michael T Bretscher

      • Abstract

      Loading...

    • +

      P09.61 - Epidemiological and Clinical Burden of EGFR Exon 20 Insertion in Advanced NSCLC: Results of a Systematic Literature Review

      00:00 - 00:00  |  Presenter: Tracy Li

      • Abstract

      Loading...

  • +

    P10 - Health Services Research/Health Economics - Health Economics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P10.01 - Bias Comparison in Studies Funded by Industry and by Other Sources: An Analysis of Prospective Studies of the Last Five Years

      00:00 - 00:00  |  Presenter: Silvio Matsas

      • Abstract

      Loading...

    • +

      P10.02 - A comparison Between the Cost of Lung Cancer Treatment and how much is made Available by Brazilian Government 

      00:00 - 00:00  |  Presenter: Marina Kelner Silveira

      • Abstract

      Loading...

    • +

      P10.03 - Health Insurance Coverage and Racial Disparities in Early-Stage Detection and Treatment of Lung Cancer: A Causal Mediation Analysis

      00:00 - 00:00  |  Presenter: Zhe Pan

      • Abstract

      Loading...

    • +

      P10.04 - A Budget Impact Analysis for Treatment with Ramucirumab Plus Erlotinib in Metastatic EGFR-Mutated NSCLC in the US

      00:00 - 00:00  |  Presenter: Katherine B. Winfree

      • Abstract

      Loading...